BioCentury
ARTICLE | Distillery Therapeutics

Infectious disease

February 28, 2017 11:51 PM UTC

Studies in cells suggest a bacterial toxin-based inhibitor of US28 could help treat latent CMV infection. In a human monocyte cell line expressing US28, a fusion protein consisting of the US28-binding...